Victory Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Victory Capital Management's ANIP Position: Q3 2026 in Review
Victory Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 763% in Q3 2026, buying an estimated $23.5M and bringing the position to 345,504 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #804.
Victory Capital Management first reported a position in ANIP in Q3 2016 and has held it in 27 quarters since. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Victory Capital Management held 345,504 shares of ANI Pharmaceuticals worth $25.1M as of Q3 2026.
- Victory Capital Management bought 305,486 ANI Pharmaceuticals shares in Q3 2026, an estimated $23.5M.
- ANI Pharmaceuticals made up 0.01% of Victory Capital Management's portfolio in Q3 2026, its #804 holding.
- Victory Capital Management first reported a position in ANI Pharmaceuticals in Q3 2016 and has held it in 27 quarters since.
- 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.